Opexa Therapeutics (OPXA) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Basic and diluted loss per share: -0.28
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Basic and diluted loss per share: -0.28
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Opexa Therapeutics (NASDAQ: OPXA) reported Q2 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Opexa Therapeutics (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
- Prenetics Global (PRE) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
